<DOC>
	<DOCNO>NCT00698945</DOCNO>
	<brief_summary>To assess additional benefit common adjunctive class diurnal IOP curve patient assess needing additional treatment reach target intraocular pressure ( IOP ) . To demonstrate superiority IOP control Istalol 0.5 % QD compare Brimonidine Tartrate 0.2 % BID adjunctive therapy adult uncontrolled IOP 's ( determine P.I . base target pressure ) currently treat Latanoprost 0.05 % study eye ( ) .</brief_summary>
	<brief_title>Comparison Istalolâ„¢ 0.5 % QD ( Timolol Maleate/Sorbitol Complex , ISTA Pharmaceutical ) Brimonidine Tartrate 0.1 % BID Adjunctive Therapy Latanoprost 0.005 % Adults With Ocular Hypertension ( OHT ) Open-Angle Glaucoma ( OAG )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Sorbitol</mesh_term>
	<criteria>1 . Patients , male female race ethnicity , 18 year age old , diagnose ocular hypertension openangle glaucoma ( without pseudoexfoliative pigmentary dispersion component ) . 2 . Stable use Latanoprost 0.005 % minimum 30 day prior screen visit . 3 . VA 20/200 good either eye 4 . Pachymetry 600 micron less 5 . Visual Field within 6 month screen visit 6 . Patients use contact lens allow participate provide remove lenses 15 minute dose 7 . Patients satisfy inform consent requirement may include study . 1 . Females childbearing potential ( surgically sterile , postmenopausal use reliable birth control method ) exclude study . 2 . Any allergic component contraindication study medication 3 . Pachymetry 600 micron great 4 . Systemic corticosteroid stable regimen within 30 day screen visit . 5 . Any concurrent topical agent discontinue course trial ( natural tear acceptable ) 6 . Significant ocular surface abnormality 7 . Patients form glaucoma ocular hypertension openangle glaucoma 8 . Patients investigational therapy within 30 day prior screen visit 9 . History ocular trauma within past 3 month 10 . Intraocular surgery within past 3 month 11 . Ocular laser surgery within past 3 month 12 . Any abnormality prevent reliable applanation tonometry either eye 13 . VA 20/200 great either eye 14 . History evidence clinically significant illness condition would make patient , opinion investigator , suitable study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>